1/21
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
What is the first step in managing the disease process?
caries risk assessment
Is caries risk assessment for diagnosis or prognosis
prognosis
Disease indicator (WREC)
white spots
Restorations (<3 years)
Enamel lesions
Caries/dentin
Risk factors (BAD)
Bad bacteria
Absence of saliva
Dietary habits (poor)
Protective factors (SAFE)
Saliva and sealants
Antibacterials
Fluoride
Effective diet
Patients with no active disease but 2 or more high-risk factors are _____ risk.
High
If patients are between risk groups, place them in the _____ risk group
higher
CAMBRA
Caries Management by Risk Assessment encompasses a methodology of identifying the cause of disease through the assessment of risk factors for each individual patient and then managing those risk factor through behavioral, chemical and minimally invasive procedures. The tool was developed in formats for use by dental providers for patients age 0 to 5 and patients age 6 through adult.
Caries risk is ultimately up to ______
the clinical judgment of the physician
The presence of active lesions and fillings (caries prevalence) show the balance between caries _______ and _______ factors have been in the past or may be at present
pathological
protective
DMFT score
caries prevalence index
Decayed, Missing, and Filled Teeth
The DMFT score is a good estimate of how much of the dentition has been affected by _____
caries
What is the most important indicator of caries risk?
past and current caries experience
How does medical history contribute to caries risk?
-medications that cause xerostomia
-conditions that make dental hygiene difficult or require carbohydrate-enriched diets
-medications containing fermentable carbohydrates such as glucose
Reassessment of a patient's caries risk should occur every ______ months depending on _____
3-12
the caries risk of the patient
For high caries risk patients, recall should be every ___ months and BW should be taken every ____ months
3
3-6
For moderate risk patients, recall should be every ____ months and BW should be taken every ____ months
3-6
12-18
For low risk patients, recall should be every ____ months and BW should be taken every ____ months
12-24
24
Treatment: An E1 or E2 lesion in a low risk patient
monitor lesion at recall appointment
Treatment: An E1 or E2 lesion in a moderate or high risk patient
lesion arrest or proximal sealant
asses lesion progression at recall appointment
Treatment: A D1 lesion in a moderate or low risk patient
lesion arrest or proximal sealant
asses lesion progression at recall appointment
Treatment: A D1 lesion in a high risk patient or D2 or D3 lesion
restoration